Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.
作者信息
Ku Elaine, Copeland Timothy P, McCulloch Charles E, Abebe Kaleab Z, Chonchol Michel, Perrone Ronald D, Rahbari-Oskoui Frederic F, Yu Alan S L, Steinman Theodore, Chapman Arlene, Sarnak Mark J
机构信息
Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California; Department of Pediatrics, Division of Pediatric Nephrology, University of California, San Francisco, San Francisco, California; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.
Division of Nephrology, Department of Medicine, University of California, San Francisco, San Francisco, California.
出版信息
Am J Kidney Dis. 2025 Jan;85(1):127-130. doi: 10.1053/j.ajkd.2024.06.020. Epub 2024 Aug 16.
Abstract
摘要
相似文献
1
Effect of Dual RAAS Blockade and Intensive BP Lowering on Risk of End-Stage Kidney Disease and Death in Autosomal Dominant Polycystic Kidney Disease: Long-term Follow-up of the HALT-PKD Trials.双重肾素-血管紧张素系统阻断与强化血压降低对常染色体显性多囊肾病患者终末期肾病风险及死亡的影响：HALT-PKD试验的长期随访
Am J Kidney Dis. 2025 Jan;85(1):127-130. doi: 10.1053/j.ajkd.2024.06.020. Epub 2024 Aug 16.
2
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies.常染色体显性多囊肾病新治疗方法的测试途径：来自CRISP和HALT-PKD研究的见解
Clin J Am Soc Nephrol. 2008 Jul;3(4):1197-204. doi: 10.2215/CJN.00060108. Epub 2008 Jun 25.
3
Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?早期常染色体显性多囊肾病进展的决定因素：是血压还是肾素-血管紧张素-醛固酮系统阻断？
Curr Hypertens Rev. 2018;14(1):39-47. doi: 10.2174/1573402114666180322110209.
4
The HALT polycystic kidney disease trials: design and implementation.HALT 多囊肾病试验：设计与实施。
Clin J Am Soc Nephrol. 2010 Jan;5(1):102-9. doi: 10.2215/CJN.04310709.
5
Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.他汀类药物治疗对常染色体显性多囊肾病进展的影响。HALT PKD试验的二次分析
Curr Hypertens Rev. 2017;13(2):109-120. doi: 10.2174/1573402113666170427142815.
6
Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.常染色体显性遗传多囊肾病患者肾功能下降的模式：HALT-PKD 试验的事后分析。
Am J Kidney Dis. 2018 May;71(5):666-676. doi: 10.1053/j.ajkd.2017.10.023. Epub 2018 Jan 3.
7
Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial.常染色体显性遗传多囊肾病临床试验中的预后富集设计：HALT-PKD 临床试验。
Nephrol Dial Transplant. 2017 Nov 1;32(11):1857-1865. doi: 10.1093/ndt/gfw294.
8
Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials.血清尿酸与常染色体显性遗传性多囊肾病的进展：来自 HALT PKD 试验的结果。
Curr Hypertens Rev. 2021;17(3):228-237. doi: 10.2174/1573402116666200817113125.
9
Angiotensin blockade in late autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病晚期的血管紧张素阻断
N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15.
10
Standardised Outcomes in Nephrology-Polycystic Kidney Disease (SONG-PKD): study protocol for establishing a core outcome set in polycystic kidney disease.肾脏病-多囊肾病标准化结局（SONG-PKD）：建立多囊肾病核心结局集的研究方案
Trials. 2017 Nov 23;18(1):560. doi: 10.1186/s13063-017-2298-4.
引用本文的文献
1
Impact of intensive blood pressure control on kidney outcomes.强化血压控制对肾脏结局的影响。
Curr Opin Nephrol Hypertens. 2025 May 1;34(3):224-231. doi: 10.1097/MNH.0000000000001070. Epub 2025 Mar 7.
本文引用的文献
1
Post-Trial Follow-Up of Kidney Outcomes in SPRINT: Some Reassurance, Some Unanswered Questions.收缩压干预试验（SPRINT）中肾脏结局的试验后随访：一些令人安心的结果，一些未解答的问题。
Clin J Am Soc Nephrol. 2024 Feb 1;19(2):145-147. doi: 10.2215/CJN.0000000000000393. Epub 2024 Jan 3.
2
US Renal Data System 2022 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2022年年报：美国肾脏疾病流行病学
Am J Kidney Dis. 2023 Mar;81(3 Suppl1):A8-A11. doi: 10.1053/j.ajkd.2022.12.001.
3
Effects of Intensive Blood Pressure Control in Patients with and without Albuminuria: Analyses from SPRINT.伴有和不伴有蛋白尿的患者强化血压控制的效果：SPRINT 分析。
Clin J Am Soc Nephrol. 2020 Aug 7;15(8):1121-1128. doi: 10.2215/CJN.12371019. Epub 2020 Jul 15.
4
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防心脏病学会/美国国家医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南：执行摘要：美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2018 Oct 23;138(17):e426-e483. doi: 10.1161/CIR.0000000000000597.
5
BP Control and Long-Term Risk of ESRD and Mortality.血压控制与终末期肾病的长期风险及死亡率
J Am Soc Nephrol. 2017 Feb;28(2):671-677. doi: 10.1681/ASN.2016030326. Epub 2016 Aug 11.
6
Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease.慢性肾脏病期间严格血压控制与终末期肾病发病后较低死亡率之间的关联。
Kidney Int. 2015 May;87(5):1055-60. doi: 10.1038/ki.2014.376. Epub 2014 Dec 10.
7
Blood pressure in early autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病早期的血压情况
N Engl J Med. 2014 Dec 11;371(24):2255-66. doi: 10.1056/NEJMoa1402685. Epub 2014 Nov 15.
8
Angiotensin blockade in late autosomal dominant polycystic kidney disease.常染色体显性遗传性多囊肾病晚期的血管紧张素阻断
N Engl J Med. 2014 Dec 11;371(24):2267-76. doi: 10.1056/NEJMoa1402686. Epub 2014 Nov 15.
9
Combined angiotensin inhibition for the treatment of diabetic nephropathy.联合应用血管紧张素抑制剂治疗糖尿病肾病。
N Engl J Med. 2013 Nov 14;369(20):1892-903. doi: 10.1056/NEJMoa1303154. Epub 2013 Nov 9.
10
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.较低目标血压对肾脏疾病进展的影响：肾脏病饮食改良研究的长期随访
Ann Intern Med. 2005 Mar 1;142(5):342-51. doi: 10.7326/0003-4819-142-5-200503010-00009.
Zotero 插件